Skip to content

Protocol of Multi-domain Attention Training

The Development and Evaluation of Multi-domain Attention Training for Older Adults With Mild Cognitive Impairment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03379519
Enrollment
60
Registered
2017-12-20
Start date
2016-08-01
Completion date
2019-12-31
Last updated
2020-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Brief summary

This study sought to investigate the changes in attention in older adults with mild cognitive impairment after Multi-domain Attention Training .

Detailed description

This double-blind randomized controlled study has a 2-arm parallel group design. All subjects will be randomized by the block randomization, into intervention group (Multi-domain Attention Training, MAT), or active control group (Passive information activities, PIA). Training sessions of the MAT group are 45 minutes/day, 3 days/week, for 12 weeks (36 sessions each). The training of PIA group is the same as MAT group. The investigators constructed a rigorous MAT program adhering to the Consolidated Standards of Reporting Trials (CONSORT) reporting guidelines. The investigators expect to determine the improvement in attention function of older adults with mild cognitive impairment after using the MAT program.

Interventions

BEHAVIORALMulti-domain Attention Training (MAT)

The training content emphasis three concept of attention include: intensity of attention, executive attention, and spatial orienting attention.

BEHAVIORALPassive information activities (PIA)

The active control group (Passive information activities) training content included reading online e-books and playing online games.

Sponsors

Ministry of Science and Technology, Taiwan
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Participants must endorse at least two items from a list of frequent subjective memory complaints by patient and/or an informant * Objective memory impairment on neuropsychological tests of memory 1.5 SD or more below age/education norms * Clinical neurologic examination by the Mini-Mental State Examination (MMSE) score of 24 or higher * No impairment in personal activities of daily living (P-ADL) as determined by clinical interview with participant and family

Exclusion criteria

* The clinical diagnosis of dementia was based on the DSM-IV-TR * Active in another cognitive or memory-related training in the past year * Comorbid medical conditions that would predispose them to imminent functional decline or cognitive impairment * A diagnosis of major neurological or psychiatric illness history and/or behavioral problems that would sufficiently impair performance to make participation impossible * Severe losses in vision, hearing, or communicative ability

Design outcomes

Primary

MeasureTime frameDescription
Change in attention as measured by the Digit Span Task (DS).Change from baseline in executive attention at Immediate post-test, 3 months, 6 months after intervention.The primary outcome indicators is executive attention assessed by the Digit Span Task (DS).

Secondary

MeasureTime frameDescription
Change in attention as measured by the Trail Making Test (TMT).Change from baseline in spatial orienting attention at Immediate post-test, 3 months, 6 months after intervention.The secondary outcome indicator is spatial orienting attention evaluated by the Trail Making Test.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026